• RLX Technology recently reported strong fiscal Q1 2026 results, with revenue nearly doubling year over year and profitability improving as international expansion and a European acquisition contributed to higher gross margins and net income growth.
• At the same time, a reminder from Kessler Topaz Meltzer & Check, LLP about an upcoming deadline in a securities fraud class action lawsuit highlights the legal backdrop investors must weigh alongside RLX’s operating momentum.
• We’ll now examine how the stronger Q1 earnings, particularly from faster international expansion, could reshape RLX Technology’s existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 49 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

RLX Technology Investment Narrative Recap

To own RLX Technology, you need to believe the company can turn the global shift toward regulated nicotine alternatives into durable, profitable growth while managing heavy regulatory and legal scrutiny. The strong Q1 2026 results support the near term earnings catalyst around international expansion, but the securities fraud class action reminder keeps legal and governance risk firmly in view and may be the most immediate overhang on the stock’s story right now.

Among recent updates, Q1 2026 earnings are most relevant here. Revenue rose to CNY 1,585.82 million with net income of CNY 284.14 million, reflecting contributions from international growth and a European acquisition. These results reinforce the existing catalyst that tighter regulation can favor compliant players such as RLX, but they also raise the stakes for how well the company handles ongoing overseas integration and legal scrutiny at the same time.

Yet alongside the growth from international expansion and acquisitions, the unresolved securities litigation is a risk investors should be aware of...

RLX Technology's narrative projects CN¥7.8 billion revenue and CN¥1.4 billion earnings by 2029.

Uncover how RLX Technology's forecasts yield a $3.14 fair value, a 58% upside to its current price.

Exploring Other Perspectives

The lowest ranked analysts painted a much more cautious picture, even before this news, assuming revenue of about CN¥7.6 billion and CN¥1.5 billion in earnings by 2029, so you should weigh that more pessimistic view alongside the recent Q1 beat and the ongoing legal overhang.

Explore 2 other fair value estimates on RLX Technology - why the stock might be worth 48% less than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your RLX Technology research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free RLX Technology research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate RLX Technology's overall financial health at a glance.

Seeking Other Investments?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.